Intercept Pharmaceuticals (ICPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 81,661 | 4,548 | 79,521 | 77,249 | 72,652 |
| Cost of Goods | 810 | -2,202 | 1,826 | 1,877 | 852 |
| Gross Profit | 80,851 | 6,750 | 77,695 | 75,372 | 71,800 |
| Operating Expenses | 111,008 | 45,637 | 133,684 | 128,279 | 156,097 |
| Operating Income | -29,347 | -39,089 | -55,163 | -52,030 | -83,445 |
| Interest Expense | 12,419 | 12,253 | 12,091 | 11,933 | 11,777 |
| Other Income | 1,346 | 675 | 785 | 682 | 2,239 |
| Pre-tax Income | -40,420 | -50,667 | -66,469 | -63,281 | -92,983 |
| Net Income Continuous | -40,420 | -50,667 | -66,469 | -63,281 | -92,983 |
| Net Income | $-40,420 | $-52,147 | $-66,469 | $-63,281 | $-92,983 |
| EPS Basic Total Ops | -1.22 | -1.55 | -2.01 | -1.92 | -2.86 |
| EPS Basic Continuous Ops | -1.22 | -1.50 | -2.01 | -1.92 | -2.86 |
| EPS Diluted Total Ops | -1.22 | -1.55 | -2.01 | -1.92 | -2.86 |
| EPS Diluted Continuous Ops | -1.22 | -1.50 | -2.01 | -1.92 | -2.86 |
| EBITDA(a) | $-19,725 | $-29,673 | $-45,977 | $-43,369 | $-75,255 |